The Centers for Medicare & Medicaid Services yesterday announced additional proposed changes to Medicare Advantage and Part D payment policies for calendar year 2019. CMS anticipates the MA plans and Part D sponsors will see an average revenue increase of 1.84%, excluding an expected 3.1% increase in risk scores. In December, CMS proposed changes to the risk adjustment model for aged and disabled beneficiaries enrolled in MA Part C plans beginning in calendar year 2019, as required by the 21st Century Cures Act. CMS must phase in the new risk adjustment model over four years and proposes using a 25% to 75% blend of the new and previous risk adjustment model for 2019. The agency also proposes to update the MA risk adjustment models for end-stage renal disease and Part D plans in 2019, among other changes. In addition, CMS proposes several changes to combat opioid overuse, including adding hard safety edits at the point-of-sale that limit supply to seven days. AHA will provide more information on the proposed changes to members soon. CMS will accept comments on the new notice through March 5 and on the December notice through March 2, and expects to publish final notices on April 2.

Related News Articles

Headline
The AHA Dec. 11 expressed support for the reintroduction of the Future Advancement of Academic Nursing, bicameral legislation that would increase nursing…
Headline
The Centers for Medicare & Medicaid Services released guidance Dec. 8 for states implementing Medicaid community engagement requirements outlined by the…
Headline
The Medicare Payment Advisory Commission Dec. 4 and 5 discussed draft payment update recommendations for 2027, which the commission will vote on in January.…
Headline
The House Dec. 1 passed the Hospital Inpatient Services Modernization Act (H.R. 4313), legislation extending certain Medicare waivers authorizing the hospital-…
Headline
The Centers for Medicare & Medicaid Services announced Dec. 1 that it intends to expand the Inpatient Rehabilitation Facility Review Choice Demonstration…
Headline
The Centers for Medicare & Medicaid Services Nov. 25 announced lower prices for 15 Medicare Part D drugs selected for the second cycle of negotiations…